Chief Accounting Officer
Sarepta Therapeutics, Inc. (SRPT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Ian Estepan is recorded as CFO, COO and Chief Accounting Officer at Sarepta Therapeutics, Inc. (SRPT). Sarepta Therapeutics, Inc. reported in an 8-K filed July 16, 2025 that Ian Estepan was appointed President and Chief Operating Officer, effective July 16, 2025. Ian Estepan has spoken on 18 earnings calls and 1 other investor event across 1 company, most recently for Sarepta Therapeutics, Inc. on March 3, 2026.
“On July 14, 2025, the Board appointed Ian Estepan as the Company's President and Chief Operating Officer, Louise Rodino-Klapac, Ph.D. as the Company's President, Research and Development and Technical Operations, and Ryan Wong as the Company's Executive Vice President, Chief Financial Officer, each effective as of July 16, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2025-07-16–present
2020-12-14–present
Recorded roles and call appearances connecting this person to public companies.
CFO, COO, Chief Accounting Officer
2020-12-14–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
